IVCVMay 5, 2025

RobSurv: Vector Quantization-Based Multi-Modal Learning for Robust Cancer Survival Prediction

arXiv:2505.02529v1h-index: 3
Originality Incremental advance
AI Analysis

This addresses the challenge of reliable clinical prognosis for cancer patients using noisy imaging data, representing a strong specific gain rather than a foundational advance.

The paper tackled the problem of robust cancer survival prediction from multi-modal medical imaging by introducing RobSurv, a framework using vector quantization and dual-path architecture, which achieved concordance indices of 0.771, 0.742, and 0.734 on three datasets and maintained performance with only 3.8-4.5% degradation under noise.

Cancer survival prediction using multi-modal medical imaging presents a critical challenge in oncology, mainly due to the vulnerability of deep learning models to noise and protocol variations across imaging centers. Current approaches struggle to extract consistent features from heterogeneous CT and PET images, limiting their clinical applicability. We address these challenges by introducing RobSurv, a robust deep-learning framework that leverages vector quantization for resilient multi-modal feature learning. The key innovation of our approach lies in its dual-path architecture: one path maps continuous imaging features to learned discrete codebooks for noise-resistant representation, while the parallel path preserves fine-grained details through continuous feature processing. This dual representation is integrated through a novel patch-wise fusion mechanism that maintains local spatial relationships while capturing global context via Transformer-based processing. In extensive evaluations across three diverse datasets (HECKTOR, H\&N1, and NSCLC Radiogenomics), RobSurv demonstrates superior performance, achieving concordance index of 0.771, 0.742, and 0.734 respectively - significantly outperforming existing methods. Most notably, our model maintains robust performance even under severe noise conditions, with performance degradation of only 3.8-4.5\% compared to 8-12\% in baseline methods. These results, combined with strong generalization across different cancer types and imaging protocols, establish RobSurv as a promising solution for reliable clinical prognosis that can enhance treatment planning and patient care.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes